Insider Transactions in Q3 2023 at Singular Genomics Systems, Inc. (OMIC)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
14,584
+0.37%
|
-
|
|
Sep 15
2023
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
14,584
-59.89%
|
-
|
|
Sep 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,584
+37.46%
|
-
|
|
Sep 15
2023
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.17%
|
-
|
|
Sep 15
2023
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+3.22%
|
-
|
|
Sep 15
2023
|
Sam Ropp Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,187
+33.33%
|
-
|
|
Aug 15
2023
|
Kim P. Kamdar |
SELL
Open market or private sale
|
Indirect |
200,000
-5.05%
|
$0
$0.53 P/Share
|
|
Aug 14
2023
|
Kim P. Kamdar |
SELL
Open market or private sale
|
Indirect |
77,991
-1.93%
|
$0
$0.57 P/Share
|
|
Aug 11
2023
|
Kim P. Kamdar |
SELL
Open market or private sale
|
Indirect |
353,657
-8.05%
|
$0
$0.6 P/Share
|